HELLO! speaks to nutritionist and exercise scientist Amelia Phillips and GP Dr Crystal Wyllie for the low down on weight loss ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing ...

GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® End-to-end GLP-1 care done right: ...

Just this week, the World Health Organization released new guidelines recommending GLP-1 therapies as a long-term treatment for adults with obesity.

End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment “GoodRx is scaling a consumer-first model for affordable GLP-1 ...

Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among ...

Berberine may support weight loss efforts. Research suggests it may help lower BMI and reduce waist size when used alongside ...

Eli Lilly cuts cash prices for Zepbound weight-loss vials on LillyDirect, offering doses from $299 to $449 as demand for ...

New pill versions of weight loss drugs, lower prices, and patent expirations will all drive GLP-1 demand in 2026 ...

Ozempic®, one brand name for semaglutide, is a diabetes drug that can be prescribed off-label for weight loss. It works by suppressing appetite, making you feel fuller, curbing cravings, and dialing ...